Cargando…
Compounded medication for patients with rare diseases
BACKGROUND: When there is no authorized on- or in absence even no off-label treatment for patients with rare diseases, pharmacists have to compound medicinal products to meet the patients special needs. However it is important that there is evidence in the medical and/or pharmaceutical literature fo...
Autores principales: | Dooms, Marc, Carvalho, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753439/ https://www.ncbi.nlm.nih.gov/pubmed/29301541 http://dx.doi.org/10.1186/s13023-017-0741-y |
Ejemplares similares
-
Pharmacists are initiators in palliative care for patients with rare diseases
por: Dooms, M.
Publicado: (2023) -
Orphan medical devices have come a long way
por: Dooms, M.
Publicado: (2023) -
Orphan devices: yesterday is history; tomorrow is mystery: towards a European orphan device directive?
por: Dooms, Marc M
Publicado: (2016) -
Epidemiology of rare diseases in Brazil: protocol of the Brazilian Rare Diseases Network (RARAS-BRDN)
por: Félix, Têmis Maria, et al.
Publicado: (2022) -
eHealth for patients with rare diseases: the eHealth Working Group of the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN)
por: Paglialonga, Alessia, et al.
Publicado: (2021)